GlassScriptPhysician profile
Kimberly Franks
NPI 1386123644
$2,262.09
in general payments reported to CMS, 2019-2025
31 companies · $565 in 2025
The $565 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $245 · 2022: $545 · 2023: $497 · 2024: $410 · 2025: $565.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,472.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,472.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $409.60 | 2021-2025 | |
| Astrazeneca Pharmaceuticals LP | $350.13 | 2021-2025 | Airsupra, Breztri, Farxiga |
| Lilly USA, LLC | $235.80 | 2022-2025 | Mounjaro, Zepbound |
| Novo Nordisk INC | $220.47 | 2021-2024 | Ozempic, Rybelsus, Wegovy |
| Exact Sciences Corporation | $162.74 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Glaxosmithkline, LLC. | $108.85 | 2022-2025 | Trelegy Ellipta, Arexvy, Shingrix |
| Boehringer Ingelheim Pharmaceuticals, INC. | $104.57 | 2021-2025 | Jardiance |
| Abbott Laboratories | $83.61 | 2023-2024 | Freestyle Libre 3 |
| Biohaven Pharmaceutical Holding Company LTD. | $61.12 | 2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $48.41 | 2021-2022 | |
| Astellas Pharma US INC | $45.96 | 2022-2025 | Veozah |
| Shield Therapeutics INC | $42.38 | 2025 | |
| Pfizer INC. | $42.27 | 2025 | |
| Eisai INC. | $29.49 | 2021 | |
| Dynavax Technologies Corporation | $29.40 | 2021-2023 | Heplisav-B |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $25.54 | 2022 | |
| Sanofi-Aventis U.S. LLC | $23.93 | 2025 | |
| Gilead Sciences, INC. | $23.77 | 2025 | |
| Novartis Pharmaceuticals Corporation | $19.92 | 2025 | |
| Hologic Sales and Service, LLC | $19.39 | 2022 | |
| Dexcom, INC. | $19.19 | 2023 | Dexcom G6 Transmitter |
| Paratek Pharmaceuticals, INC. | $18.38 | 2021 | |
| Merck Sharp & Dohme LLC | $18.02 | 2023 | Vaxelis, Gardasil 9, M-M-R II |
| Amarin Pharma, INC. | $17.93 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $16.63 | 2024 | |
| Idorsia Pharmaceuticals US INC | $15.44 | 2023 | Quviviq |
| Takeda Pharmaceuticals U.S.A., INC. | $15.10 | 2021 | |
| Amgen INC. | $14.49 | 2025 | Evenity |
| Biohaven Pharmaceuticals, INC. | $14.46 | 2021 | |
| Antares Pharma, INC. | $13.30 | 2022 | |
| Currax Pharmaceuticals LLC | $11.80 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kimberly Franks listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.